Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diatrizoic acid
Drug ID BADD_D00647
Description A commonly used x-ray contrast medium. As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
Indications and Usage Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.
Marketing Status approved; vet_approved
ATC Code V08AA01
DrugBank ID DB00271
KEGG ID D02240
MeSH ID D003973
PubChem ID 2140
TTD Drug ID D0T9DT
NDC Product Code Not Available
UNII 5UVC90J1LK
Synonyms Diatrizoate | Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo- | Hypaque | Diatrizoic Acid | Urothrast | Urotrast | Urogranoic Acid | Sodium Diatrizoate | Diatrizoate, Sodium | Diatrizoate Sodium | Sodium-Magnesium Diatrizoate | Diatrizoate, Sodium-Magnesium | Amidotrezoate | Amidotrizoate | Hypaque 50
Chemical Information
Molecular Formula C11H9I3N2O4
CAS Registry Number 117-96-4
SMILES CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Coma17.02.09.001--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Conjunctival oedema06.04.01.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Contrast media reaction12.02.05.029; 10.01.01.011--Not Available
Conversion disorder19.24.01.001--Not Available
Cough22.02.03.001--
Cyanosis22.02.02.007; 23.06.04.005; 02.11.04.004; 24.03.01.007--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Disseminated intravascular coagulation24.01.01.010; 01.01.02.002--
Dizziness17.02.05.003; 02.11.04.006; 24.06.02.007--
Drug interaction08.06.03.001--Not Available
Dry throat22.12.03.005; 07.06.01.005--Not Available
Dysgeusia17.02.07.003; 07.14.03.001--
Dysphagia07.01.06.003--
Dysphonia22.12.03.006; 19.19.03.002; 17.02.08.004--
Dyspnoea02.11.05.003; 22.02.01.004--
Electrocardiogram abnormal13.14.05.001--Not Available
Erythema23.03.06.001--Not Available
Extravasation08.01.03.008--Not Available
Eye discharge06.04.05.001--Not Available
Eye disorder06.08.03.001--Not Available
Eye inflammation06.04.05.002--Not Available
Eye irritation06.04.05.003--Not Available
Eyelid oedema06.04.04.004; 23.04.01.003; 10.01.05.001--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Feeling abnormal08.01.09.014--Not Available
Feeling hot08.01.09.009--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 6 Pages